How to classify women exposed to drug prescriptions during pregnancy in pharmaco-epidemiology studies? Method using treatment intensity and individual trajectories of exposure over time

21/11/2014
01/04/2024
EU PAS number:
EUPAS8001
Study
Finalised
Study type

Study topic

Disease /health condition
Human medicinal product

Study type

Not applicable

If ‘Not applicable’, further details on the study type

Development of new methods in Pharmacoepidemiology
Study drug and medical condition

Anatomical Therapeutic Chemical (ATC) code

(N05) PSYCHOLEPTICS
PSYCHOLEPTICS
(N06) PSYCHOANALEPTICS
PSYCHOANALEPTICS
Population studied

Short description of the study population

Women exposed to psychotropic drugs during pregnancy in EFEMERIS database.

Age groups

  • Adults (18 to < 46 years)

Special population of interest

Pregnant women

Estimated number of subjects

3700
Study design details

Main study objective

The objective of the present study is to propose a new method to classify women according to drug exposure during pregnancy taking into account treatment intensity, duration and evolution.We will apply this method to psychotropic drugs during pregnancy in EFEMERIS.

Data analysis plan

With the proposed method, pregnant women are classified according to drug exposure taking into account treatment intensity and prescription evolution during pregnancy. Three steps are required to set up the new method : 1.Convertion of filled prescriptions into exposure variables (using ATC-DDD) 2.Construction of individual trajectories of exposure 3.Classification of individual trajectories of exposure in homogeneous groups.